文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中枢神经系统癌症,第 3.2020 版,NCCN 肿瘤学临床实践指南。

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

机构信息

1O'Neal Comprehensive Cancer Center at UAB.

2City of Hope National Medical Center.

出版信息

J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537-1570. doi: 10.6004/jnccn.2020.0052.


DOI:10.6004/jnccn.2020.0052
PMID:33152694
Abstract

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.

摘要

NCCN 中枢神经系统(CNS)癌症指南侧重于成人 CNS 癌症的管理,涵盖了从非侵袭性和可通过手术治愈的毛细胞星形细胞瘤到转移性脑疾病等各种情况。多学科团队的参与,包括神经外科医生、放射治疗师、肿瘤学家、神经学家和神经放射学家,是 CNS 癌症适当管理的关键因素。脑肿瘤(如神经胶质瘤)的综合组织病理学和分子特征分析应成为标准做法。本文介绍了 NCCN 指南针对 WHO 分级 I、II、III 和 IV 级神经胶质瘤的推荐治疗方案。此外,本文还描述了成人中最常见的颅内肿瘤——脑转移瘤的治疗方法。

相似文献

[1]
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2020-11-2

[2]
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

J Natl Compr Canc Netw. 2023-1

[3]
Central Nervous System Cancers, Version 1.2015.

J Natl Compr Canc Netw. 2015-10

[4]
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

Nat Rev Clin Oncol. 2021-3

[5]
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2022-12

[6]
[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)].

Bull Cancer. 2003-10

[7]
Central nervous system cancers.

J Natl Compr Canc Netw. 2013-9-1

[8]
[CLINICAL GUIDELINES FOR DIAGNOSING, TREATING AND MONITORING OF ADULT PATIENTS WITH GLIOMAS OF CENTRAL NERVOUS SYSTEM].

Lijec Vjesn. 2015

[9]
Multidisciplinary management of adult low grade gliomas.

Chirurgia (Bucur). 2014

[10]
Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.

Australas Radiol. 2001-11

引用本文的文献

[1]
Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches.

Biomedicines. 2025-8-12

[2]
Single Pontine Relapse Shortly After Hippocampal Avoidance Whole Brain Radiotherapy: A Case Report.

Cancer Rep (Hoboken). 2025-8

[3]
Stereotactic radiosurgery for brain metastasis from gynecological cancers: A systematic review.

Neurooncol Adv. 2025-6-20

[4]
Stereotactic Radiosurgery for Patients with Brain Metastases from Sarcomas.

Cancers (Basel). 2025-6-24

[5]
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort.

Acta Neuropathol Commun. 2025-6-28

[6]
Magnetic Resonance Imaging Radiomics-Driven Artificial Neural Network Model for Advanced Glioma Grading Assessment.

Medicina (Kaunas). 2025-6-3

[7]
Clinical impact following the establishment of a specialized brain metastases tumor board.

Clin Transl Oncol. 2025-6-23

[8]
Unveiling the dual role of circulating tumor cells in colorectal cancer immunotherapy: a comprehensive review of biomarker utility and immune microenvironment crosstalk.

Front Immunol. 2025-6-6

[9]
Palliative care in patients with glioblastoma: A systematic review.

Med Int (Lond). 2025-5-28

[10]
Diagnosis and therapeutic targeting of quiescent cancer cells: road to conquer cancer recurrence.

BMB Rep. 2025-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索